Education
About Us
Working with TipRanks
Follow Us
Robert Gould Insider Profile
4 Followers
Robert Gould, Director at Epizyme, holds 469.86K shares in Fulcrum Therapeutics (Ticker: FULC), holds 0.00 shares in Epizyme (Ticker: EPZM), holds ― shares in Turnstone Biologics Corp. (Ticker: TSBX).
Robert Gould Epizyme (EPZM)Director
Epizyme (EPZM)
Director
Not Ranked
Robert Gould has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
Director
Roles that Robert Gould holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Robert Gould
Robert Gould's Trading History
Epizyme
Dec 30, 2015
―
Uninformative Sell
578.06K
$0.00
Fulcrum Therapeutics
Jan 06, 2026
Director
Uninformative Sell
178.05K
$4.75M
Turnstone Biologics Corp.
―
―
―
―
List of latest transactions for each holding click on a transaction to see Robert Gould's performance on stock
You May Also Like
Robert Gould insider profile FAQ
What is the percentage of profitable transactions made by Robert Gould?
The percentage of profitable transactions made by Robert Gould is ―.
What is the average return per transaction made by Robert Gould?
The average return per transaction made by Robert Gould is ―.
What stocks does Robert Gould hold?
Robert Gould holds: EPZM, FULC, TSBX stocks.
What was Robert Gould’s latest transaction?
Robert Gould latest transaction was an Uninformative Sell of $178.05K.
What was Robert Gould's most profitable transaction?
Robert Gould’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Robert Gould's role in Epizyme?
Robert Gould's role in Epizyme is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.